img

Global and United States Pharmaceutical CRDMO Service Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Software

Publisher : MRA | Format : PDF

Global and United States Pharmaceutical CRDMO Service Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Pharmaceutical CRDMO Service Market
This report focuses on global and United States Pharmaceutical CRDMO Service market, also covers the segmentation data of other regions in regional level and county level.
The global Pharmaceutical CRDMO Service revenue was US$ 83 million in 2023 and is forecast to a readjusted size of US$ 130.6 million by 2033 with a CAGR of 6.8% during the review period (2023-2033).
In United States the Pharmaceutical CRDMO Service revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Pharmaceutical CRDMO Service include BioDuro-Sundia, Sai Life Sciences, Icosagen, WuXi Biologics, WuXi AppTec, Esco Aster, Jubilant Biosys, Syngene International and Chemveda, etc. The global five biggest players hold a share of % in 2023.
Global Pharmaceutical CRDMO Service Scope and Market Size
Pharmaceutical CRDMO Service market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Pharmaceutical CRDMO Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Pharmaceutical CRDMO Service market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


BioDuro-Sundia
Sai Life Sciences
Icosagen
WuXi Biologics
WuXi AppTec
Esco Aster
Jubilant Biosys
Syngene International
Chemveda
Ardena Holding
Eurofins
Jiangsu HUAYI Technology Co., Ltd.
Segment by Type
Small Molecule CRDMO Service
Middle Molecule CRDMO Service
Large Molecule CRDMO Service

Segment by Application


Oncology
Infectious Disease
Neurology
Immunology
Hematology
Vaccine
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Pharmaceutical CRDMO Service definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Pharmaceutical CRDMO Service companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Pharmaceutical CRDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CRDMO Service revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Pharmaceutical CRDMO Service Product Introduction
1.2 Global Pharmaceutical CRDMO Service Outlook 2018 VS 2023 VS 2033
1.2.1 Global Pharmaceutical CRDMO Service Market Size for the Year 2018-2033
1.2.2 United States Pharmaceutical CRDMO Service Market Size for the Year 2018-2033
1.3 Pharmaceutical CRDMO Service Market Size, United States VS Global, 2018 VS 2023 VS 2033
1.3.1 The Market Share of United States Pharmaceutical CRDMO Service in Global, 2018 VS 2023 VS 2033
1.3.2 The Growth Rate of Pharmaceutical CRDMO Service Market Size, United States VS Global, 2018 VS 2023 VS 2033
1.4 Pharmaceutical CRDMO Service Market Dynamics
1.4.1 Pharmaceutical CRDMO Service Industry Trends
1.4.2 Pharmaceutical CRDMO Service Market Drivers
1.4.3 Pharmaceutical CRDMO Service Market Challenges
1.4.4 Pharmaceutical CRDMO Service Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Pharmaceutical CRDMO Service by Type
2.1 Pharmaceutical CRDMO Service Market Segment by Type
2.1.1 Small Molecule CRDMO Service
2.1.2 Middle Molecule CRDMO Service
2.1.3 Large Molecule CRDMO Service
2.2 Global Pharmaceutical CRDMO Service Market Size by Type (2018, 2023 & 2033)
2.3 Global Pharmaceutical CRDMO Service Market Size by Type (2018-2033)
2.4 United States Pharmaceutical CRDMO Service Market Size by Type (2018, 2023 & 2033)
2.5 United States Pharmaceutical CRDMO Service Market Size by Type (2018-2033)
3 Pharmaceutical CRDMO Service by Application
3.1 Pharmaceutical CRDMO Service Market Segment by Application
3.1.1 Oncology
3.1.2 Infectious Disease
3.1.3 Neurology
3.1.4 Immunology
3.1.5 Hematology
3.1.6 Vaccine
3.1.7 Others
3.2 Global Pharmaceutical CRDMO Service Market Size by Application (2018, 2023 & 2033)
3.3 Global Pharmaceutical CRDMO Service Market Size by Application (2018-2033)
3.4 United States Pharmaceutical CRDMO Service Market Size by Application (2018, 2023 & 2033)
3.5 United States Pharmaceutical CRDMO Service Market Size by Application (2018-2033)
4 Global Pharmaceutical CRDMO Service Competitor Landscape by Company
4.1 Global Pharmaceutical CRDMO Service Market Size by Company
4.1.1 Global Key Companies of Pharmaceutical CRDMO Service, Ranked by Revenue (2023)
4.1.2 Global Pharmaceutical CRDMO Service Revenue by Player (2018-2023)
4.2 Global Pharmaceutical CRDMO Service Concentration Ratio (CR)
4.2.1 Pharmaceutical CRDMO Service Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Pharmaceutical CRDMO Service in 2023
4.2.3 Global Pharmaceutical CRDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Pharmaceutical CRDMO Service Head office and Area Served
4.4 Global Key Players of Pharmaceutical CRDMO Service, Product and Application
4.5 Global Key Players of Pharmaceutical CRDMO Service, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Pharmaceutical CRDMO Service Market Size by Company
4.7.1 Key Players of Pharmaceutical CRDMO Service in United States, Ranked by Revenue (2023)
4.7.2 United States Pharmaceutical CRDMO Service Revenue by Players (2021, 2023 & 2023)
5 Global Pharmaceutical CRDMO Service Market Size by Region
5.1 Global Pharmaceutical CRDMO Service Market Size by Region: 2018 VS 2023 VS 2033
5.2 Global Pharmaceutical CRDMO Service Market Size by Region (2018-2033)
5.2.1 Global Pharmaceutical CRDMO Service Market Size by Region: 2018-2023
5.2.2 Global Pharmaceutical CRDMO Service Market Size by Region (2024-2033)
6 Americas
6.1 Americas Pharmaceutical CRDMO Service Market Size YoY Growth 2018-2033
6.2 Americas Pharmaceutical CRDMO Service Market Size by Type
6.2.1 Americas Pharmaceutical CRDMO Service Market Size by Type (2018-2023)
6.2.2 Americas Pharmaceutical CRDMO Service Market Size by Type (2024-2033)
6.2.3 Americas Pharmaceutical CRDMO Service Market Share by Type (2018-2033)
6.3 Americas Pharmaceutical CRDMO Service Market Size by Application
6.3.1 Americas Pharmaceutical CRDMO Service Market Size by Application (2018-2023)
6.3.2 Americas Pharmaceutical CRDMO Service Market Size by Application (2024-2033)
6.3.3 Americas Pharmaceutical CRDMO Service Market Share by Application (2018-2033)
6.4 Americas Pharmaceutical CRDMO Service Market Facts & Figures by Country (2018, 2023 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Pharmaceutical CRDMO Service Market Size YoY Growth 2018-2033
7.2 EMEA Pharmaceutical CRDMO Service Market Size by Type
7.2.1 EMEA Pharmaceutical CRDMO Service Market Size by Type (2018-2023)
7.2.2 EMEA Pharmaceutical CRDMO Service Market Size by Type (2024-2033)
7.2.3 EMEA Pharmaceutical CRDMO Service Market Share by Type (2018-2033)
7.3 EMEA Pharmaceutical CRDMO Service Market Size by Application
7.3.1 EMEA Pharmaceutical CRDMO Service Market Size by Application (2018-2023)
7.3.2 EMEA Pharmaceutical CRDMO Service Market Size by Application (2024-2033)
7.3.3 EMEA Pharmaceutical CRDMO Service Market Share by Application (2018-2033)
7.4 EMEA Pharmaceutical CRDMO Service Market Facts & Figures by Country (2018, 2023 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Pharmaceutical CRDMO Service Market Size YoY Growth 2018-2033
8.2 China Pharmaceutical CRDMO Service Market Size by Type
8.2.1 China Pharmaceutical CRDMO Service Market Size by Type (2018-2023)
8.2.2 China Pharmaceutical CRDMO Service Market Size by Type (2024-2033)
8.2.3 China Pharmaceutical CRDMO Service Market Share by Type (2018-2033)
8.3 China Pharmaceutical CRDMO Service Market Size by Application
8.3.1 China Pharmaceutical CRDMO Service Market Size by Application (2018-2023)
8.3.2 China Pharmaceutical CRDMO Service Market Size by Application (2024-2033)
8.3.3 China Pharmaceutical CRDMO Service Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Pharmaceutical CRDMO Service Market Size YoY Growth 2018-2033
9.2 APAC Pharmaceutical CRDMO Service Market Size by Type
9.2.1 APAC Pharmaceutical CRDMO Service Market Size by Type (2018-2023)
9.2.2 APAC Pharmaceutical CRDMO Service Market Size by Type (2024-2033)
9.2.3 APAC Pharmaceutical CRDMO Service Market Share by Type (2018-2033)
9.3 APAC Pharmaceutical CRDMO Service Market Size by Application
9.3.1 APAC Pharmaceutical CRDMO Service Market Size by Application (2018-2023)
9.3.2 APAC Pharmaceutical CRDMO Service Market Size by Application (2024-2033)
9.3.3 APAC Pharmaceutical CRDMO Service Market Share by Application (2018-2033)
9.4 APAC Pharmaceutical CRDMO Service Market Facts & Figures by Country (2018, 2023 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 BioDuro-Sundia
10.1.1 BioDuro-Sundia Company Details
10.1.2 BioDuro-Sundia Business Overview
10.1.3 BioDuro-Sundia Pharmaceutical CRDMO Service Introduction
10.1.4 BioDuro-Sundia Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.1.5 BioDuro-Sundia Recent Development
10.2 Sai Life Sciences
10.2.1 Sai Life Sciences Company Details
10.2.2 Sai Life Sciences Business Overview
10.2.3 Sai Life Sciences Pharmaceutical CRDMO Service Introduction
10.2.4 Sai Life Sciences Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.2.5 Sai Life Sciences Recent Development
10.3 Icosagen
10.3.1 Icosagen Company Details
10.3.2 Icosagen Business Overview
10.3.3 Icosagen Pharmaceutical CRDMO Service Introduction
10.3.4 Icosagen Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.3.5 Icosagen Recent Development
10.4 WuXi Biologics
10.4.1 WuXi Biologics Company Details
10.4.2 WuXi Biologics Business Overview
10.4.3 WuXi Biologics Pharmaceutical CRDMO Service Introduction
10.4.4 WuXi Biologics Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.4.5 WuXi Biologics Recent Development
10.5 WuXi AppTec
10.5.1 WuXi AppTec Company Details
10.5.2 WuXi AppTec Business Overview
10.5.3 WuXi AppTec Pharmaceutical CRDMO Service Introduction
10.5.4 WuXi AppTec Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.5.5 WuXi AppTec Recent Development
10.6 Esco Aster
10.6.1 Esco Aster Company Details
10.6.2 Esco Aster Business Overview
10.6.3 Esco Aster Pharmaceutical CRDMO Service Introduction
10.6.4 Esco Aster Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.6.5 Esco Aster Recent Development
10.7 Jubilant Biosys
10.7.1 Jubilant Biosys Company Details
10.7.2 Jubilant Biosys Business Overview
10.7.3 Jubilant Biosys Pharmaceutical CRDMO Service Introduction
10.7.4 Jubilant Biosys Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.7.5 Jubilant Biosys Recent Development
10.8 Syngene International
10.8.1 Syngene International Company Details
10.8.2 Syngene International Business Overview
10.8.3 Syngene International Pharmaceutical CRDMO Service Introduction
10.8.4 Syngene International Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.8.5 Syngene International Recent Development
10.9 Chemveda
10.9.1 Chemveda Company Details
10.9.2 Chemveda Business Overview
10.9.3 Chemveda Pharmaceutical CRDMO Service Introduction
10.9.4 Chemveda Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.9.5 Chemveda Recent Development
10.10 Ardena Holding
10.10.1 Ardena Holding Company Details
10.10.2 Ardena Holding Business Overview
10.10.3 Ardena Holding Pharmaceutical CRDMO Service Introduction
10.10.4 Ardena Holding Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.10.5 Ardena Holding Recent Development
10.11 Eurofins
10.11.1 Eurofins Company Details
10.11.2 Eurofins Business Overview
10.11.3 Eurofins Pharmaceutical CRDMO Service Introduction
10.11.4 Eurofins Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.11.5 Eurofins Recent Development
10.12 Jiangsu HUAYI Technology Co., Ltd.
10.12.1 Jiangsu HUAYI Technology Co., Ltd. Company Details
10.12.2 Jiangsu HUAYI Technology Co., Ltd. Business Overview
10.12.3 Jiangsu HUAYI Technology Co., Ltd. Pharmaceutical CRDMO Service Introduction
10.12.4 Jiangsu HUAYI Technology Co., Ltd. Revenue in Pharmaceutical CRDMO Service Business (2018-2023)
10.12.5 Jiangsu HUAYI Technology Co., Ltd. Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Pharmaceutical CRDMO Service Market Size United States VS Global, CAGR (2018 VS 2023 VS 2033)
Table 2. Pharmaceutical CRDMO Service Market Trends
Table 3. Pharmaceutical CRDMO Service Market Drivers
Table 4. Pharmaceutical CRDMO Service Market Challenges
Table 5. Pharmaceutical CRDMO Service Market Restraints
Table 6. Global Pharmaceutical CRDMO Service Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 7. United States Pharmaceutical CRDMO Service Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 8. Global Pharmaceutical CRDMO Service Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 9. United States Pharmaceutical CRDMO Service Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 10. Global Key Companies of Pharmaceutical CRDMO Service, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Pharmaceutical CRDMO Service Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Pharmaceutical CRDMO Service Revenue Share by Player, 2018-2023
Table 13. Global Pharmaceutical CRDMO Service Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharmaceutical CRDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CRDMO Service as of 2023)
Table 15. Global Key Players of Pharmaceutical CRDMO Service, Headquarters and Area Served
Table 16. Global Key Players of Pharmaceutical CRDMO Service, Product and Application
Table 17. Global Key Players of Pharmaceutical CRDMO Service, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Pharmaceutical CRDMO Service in United States, Ranked by Revenue (2023) & (US$ Million)
Table 20. United States Pharmaceutical CRDMO Service Revenue by Players, (US$ Million), 2021, 2023 & 2023
Table 21. United States Pharmaceutical CRDMO Service Revenue Share by Players, 2021, 2023 & 2023
Table 22. Global Pharmaceutical CRDMO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 23. Global Pharmaceutical CRDMO Service Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Pharmaceutical CRDMO Service Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Pharmaceutical CRDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Pharmaceutical CRDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Pharmaceutical CRDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Pharmaceutical CRDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Pharmaceutical CRDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 30. Americas Pharmaceutical CRDMO Service Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Pharmaceutical CRDMO Service Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Pharmaceutical CRDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Pharmaceutical CRDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Pharmaceutical CRDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Pharmaceutical CRDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Pharmaceutical CRDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. EMEA Pharmaceutical CRDMO Service Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Pharmaceutical CRDMO Service Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Pharmaceutical CRDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Pharmaceutical CRDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Pharmaceutical CRDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Pharmaceutical CRDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Pharmaceutical CRDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. APAC Pharmaceutical CRDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Pharmaceutical CRDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Pharmaceutical CRDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Pharmaceutical CRDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Pharmaceutical CRDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 49. APAC Pharmaceutical CRDMO Service Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Pharmaceutical CRDMO Service Market Size by Region (2024-2033) & (US$ Million)
Table 51. BioDuro-Sundia Company Details
Table 52. BioDuro-Sundia Business Overview
Table 53. BioDuro-Sundia Pharmaceutical CRDMO Service Product
Table 54. BioDuro-Sundia Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 55. BioDuro-Sundia Recent Development
Table 56. Sai Life Sciences Company Details
Table 57. Sai Life Sciences Business Overview
Table 58. Sai Life Sciences Pharmaceutical CRDMO Service Product
Table 59. Sai Life Sciences Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 60. Sai Life Sciences Recent Development
Table 61. Icosagen Company Details
Table 62. Icosagen Business Overview
Table 63. Icosagen Pharmaceutical CRDMO Service Product
Table 64. Icosagen Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 65. Icosagen Recent Development
Table 66. WuXi Biologics Company Details
Table 67. WuXi Biologics Business Overview
Table 68. WuXi Biologics Pharmaceutical CRDMO Service Product
Table 69. WuXi Biologics Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 70. WuXi Biologics Recent Development
Table 71. WuXi AppTec Company Details
Table 72. WuXi AppTec Business Overview
Table 73. WuXi AppTec Pharmaceutical CRDMO Service Product
Table 74. WuXi AppTec Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 75. WuXi AppTec Recent Development
Table 76. Esco Aster Company Details
Table 77. Esco Aster Business Overview
Table 78. Esco Aster Pharmaceutical CRDMO Service Product
Table 79. Esco Aster Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 80. Esco Aster Recent Development
Table 81. Jubilant Biosys Company Details
Table 82. Jubilant Biosys Business Overview
Table 83. Jubilant Biosys Pharmaceutical CRDMO Service Product
Table 84. Jubilant Biosys Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 85. Jubilant Biosys Recent Development
Table 86. Syngene International Company Details
Table 87. Syngene International Business Overview
Table 88. Syngene International Pharmaceutical CRDMO Service Product
Table 89. Syngene International Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 90. Syngene International Recent Development
Table 91. Chemveda Company Details
Table 92. Chemveda Business Overview
Table 93. Chemveda Pharmaceutical CRDMO Service Product
Table 94. Chemveda Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 95. Chemveda Recent Development
Table 96. Ardena Holding Company Details
Table 97. Ardena Holding Business Overview
Table 98. Ardena Holding Pharmaceutical CRDMO Service Product
Table 99. Ardena Holding Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 100. Ardena Holding Recent Development
Table 101. Eurofins Company Details
Table 102. Eurofins Business Overview
Table 103. Eurofins Pharmaceutical CRDMO Service Product
Table 104. Eurofins Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 105. Eurofins Recent Development
Table 106. Jiangsu HUAYI Technology Co., Ltd. Company Details
Table 107. Jiangsu HUAYI Technology Co., Ltd. Business Overview
Table 108. Jiangsu HUAYI Technology Co., Ltd. Pharmaceutical CRDMO Service Product
Table 109. Jiangsu HUAYI Technology Co., Ltd. Revenue in Pharmaceutical CRDMO Service Business (2018-2023) & (US$ Million)
Table 110. Jiangsu HUAYI Technology Co., Ltd. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical CRDMO Service Product Picture
Figure 2. Global Pharmaceutical CRDMO Service Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Pharmaceutical CRDMO Service Market Size 2018-2033 (US$ Million)
Figure 4. United States Pharmaceutical CRDMO Service Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 5. United States Pharmaceutical CRDMO Service Market Size 2018-2033 (US$ Million)
Figure 6. United States Pharmaceutical CRDMO Service Market Share in Global 2018-2033
Figure 7. Pharmaceutical CRDMO Service Report Years Considered
Figure 8. Product Picture of Small Molecule CRDMO Service
Figure 9. Product Picture of Middle Molecule CRDMO Service
Figure 10. Product Picture of Large Molecule CRDMO Service
Figure 11. Global Pharmaceutical CRDMO Service Market Share by Type in 2023 & 2033
Figure 12. Global Pharmaceutical CRDMO Service Market Size by Type (2018-2033) & (US$ Million)
Figure 13. Global Pharmaceutical CRDMO Service Market Share by Type (2018-2033)
Figure 14. United States Pharmaceutical CRDMO Service Market Share by Type in 2023 & 2033
Figure 15. United States Pharmaceutical CRDMO Service Market Size by Type (2018-2033) & (US$ Million)
Figure 16. United States Pharmaceutical CRDMO Service Market Share by Type (2018-2033)
Figure 17. Product Picture of Oncology
Figure 18. Product Picture of Infectious Disease
Figure 19. Product Picture of Neurology
Figure 20. Product Picture of Immunology
Figure 21. Product Picture of Hematology
Figure 22. Product Picture of Vaccine
Figure 23. Product Picture of Others
Figure 24. Global Pharmaceutical CRDMO Service Market Share by Application in 2023 & 2033
Figure 25. Global Pharmaceutical CRDMO Service Market Size by Application (2018-2033) & (US$ Million)
Figure 26. Global Pharmaceutical CRDMO Service Market Share by Application (2018-2033)
Figure 27. United States Pharmaceutical CRDMO Service Market Share by Application in 2023 & 2033
Figure 28. United States Pharmaceutical CRDMO Service Market Size by Application (2018-2033) & (US$ Million)
Figure 29. United States Pharmaceutical CRDMO Service Market Share by Application (2018-2033)
Figure 30. The Top 5 and 10 Largest Companies of Pharmaceutical CRDMO Service in the World: Market Share by Pharmaceutical CRDMO Service Revenue in 2023
Figure 31. Global Pharmaceutical CRDMO Service Market Size Market Share by Region: 2018 VS 2023 VS 2033
Figure 32. Global Pharmaceutical CRDMO Service Market Share by Region (2018-2033)
Figure 33. Americas Pharmaceutical CRDMO Service Market Size Growth Rate 2018-2033 (US$ Million)
Figure 34. Americas Pharmaceutical CRDMO Service Market Share by Type (2018-2033)
Figure 35. Americas Pharmaceutical CRDMO Service Market Share by Application (2018-2033)
Figure 36. United States Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 37. Canada Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 38. Mexico Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Brazil Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. EMEA Pharmaceutical CRDMO Service Market Size Growth Rate 2018-2033 (US$ Million)
Figure 41. EMEA Pharmaceutical CRDMO Service Market Share by Type (2018-2033)
Figure 42. EMEA Pharmaceutical CRDMO Service Market Share by Application (2018-2033)
Figure 43. Europe Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 44. Middle East Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 45. Africa Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 46. China Pharmaceutical CRDMO Service Market Size Growth Rate 2018-2033 (US$ Million)
Figure 47. China Pharmaceutical CRDMO Service Market Share by Type (2018-2033)
Figure 48. China Pharmaceutical CRDMO Service Market Share by Application (2018-2033)
Figure 49. APAC Pharmaceutical CRDMO Service Market Size Growth Rate 2018-2033 (US$ Million)
Figure 50. APAC Pharmaceutical CRDMO Service Market Share by Type (2018-2033)
Figure 51. APAC Pharmaceutical CRDMO Service Market Share by Application (2018-2033)
Figure 52. Japan Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. South Korea Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 54. China Taiwan Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 55. Southeast Asia Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 56. India Pharmaceutical CRDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 57. BioDuro-Sundia Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 58. Sai Life Sciences Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 59. Icosagen Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 60. WuXi Biologics Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 61. WuXi AppTec Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 62. Esco Aster Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 63. Jubilant Biosys Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 64. Syngene International Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 65. Chemveda Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 66. Ardena Holding Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 67. Eurofins Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 68. Jiangsu HUAYI Technology Co., Ltd. Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed